Page 85 - GTM-3-3
P. 85

Global Translational Medicine                               Graphene oxide in cancer drug delivery applications



            60.  Gong P, Zhang L, Yuan X, et al. Multifunctional fluorescent   70.  Yunus MA, Ramli MM, Osman NH, Mohamed R.
               PEGylated fluorinated  graphene for targeted drug   Stimulation of innate and adaptive immune cells with
               delivery: An experiment and DFT study.  Dyes Pigments.   graphene oxide and reduced graphene oxide affect cancer
               2019;162:573-582.                                  progression. Arch Immunol Ther Exp (Warsz). 2021;69:20.
               doi: 10.1016/j.dyepig.2018.10.031                  doi: 10.1007/s00005-021-00625-6
            61.  Gong P, Ji S, Wang J, Dai D, et al. Fluorescence-switchable   71.  Feito MJ, Diez-Orejas R, Cicuéndez M, Casarrubios L,
               ultrasmall fluorinated  graphene oxide with high near-  Rojo JM, Portolés MT. Characterization of M1 and M2
               infrared absorption for controlled and targeted drug   polarization phenotypes in peritoneal macrophages after
               delivery. Chem Eng J. 2018;348:438-446.            treatment with graphene oxide nanosheets. Colloids Surf B
                                                                  Biointerfaces. 2019;176:96-105.
               doi: 10.1016/j.cej.2018.04.193
                                                                  doi: 10.1016/j.colsurfb.2018.12.063
            62.  Sontakke AD, Tiwari S, Gupta P, Banerjee SK, Purkait MK.
               Room    temperature  synthesis  of  β-cyclodextrin   72.  Ni G, Wang Y, Wu X, Wang X, Chen S, Liu X. Graphene
               functionalized  graphene oxide decorated MIL-100 (Fe):   oxide absorbed anti-IL10R antibodies enhance LPS induced
               A sustainable drug cargo for anticancer drug delivery. Mater   immune  responses  in vitro  and  in vivo.  Immunol Lett.
               Today Commun. 2024;38:108560.                      2012;148:126-132.
               doi: 10.1016/j.mtcomm.2024.108560                  doi: 10.1016/j.imlet.2012.10.001
            63.  Aliabadi M, Yunessnia Lehi A, Shagholani H, Gerayeli A.   73.  Sinha A, Cha BG, Choi Y, et al. Carbohydrate-Functionalized
               Planar polymer-graphene oxide nanohybrid as a      rGO as an effective cancer vaccine for stimulating antigen-
               5-fluorouacil  carrier  in  pH-responsive  controlled  release.   specific cytotoxic t cells and inhibiting tumor growth. Chem
               J Drug Deliv Sci Technol. 2018;43:103-106.         Mater. 2017;29:6883-6892.
               doi: 10.1016/j.jddst.2017.09.020                   doi: 10.1021/acs.chemmater.7b02197
            64.  Parvaneh S, Pourmadadi M, Abdouss M,  et al.   74.  Zamorina SA, Shardina KY, Timganova VP, Bochkova MS,
               Carboxymethyl cellulose/starch/reduced  graphene oxide   Nechaev AI, Khramtsov P. Effect of  graphene oxide
               composite as a pH-sensitive nanocarrier for curcumin drug   nanoparticles on differentiation of myeloid suppressor cells.
               delivery. Int J Biol Macromol. 2023;241:124566.    Bull Exp Biol Med. 2020;170:84-87.
               doi: 10.1016/j.ijbiomac.2023.124566                doi: 10.1007/s10517-020-05009-y
            65.  Yang K, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. The influence   75.  Lu YJ, Vayalakkara RK, Dash BS, et al. Immunomodulatory
               of surface chemistry and size of nanoscale graphene oxide   R848-Loaded Anti-PD-L1-conjugated reduced  graphene
               on photothermal therapy of cancer using ultra-low laser   oxide quantum dots for photothermal immunotherapy of
               power. Biomaterials. 2012;33:2206-2214.            glioblastoma. Pharmaceutics. 2024;16:1064.
               doi: 10.1016/j.biomaterials.2011.11.064            doi: 10.3390/pharmaceutics16081064
            66.  Lim MH, Jeung IC, Jeong J, et al. Graphene oxide induces   76.  Deng X, Liang H, Yang W, Shao Z. Polarization and function
               apoptotic cell death in endothelial cells by activating   of tumor-associated macrophages mediate  graphene
               autophagy via calcium-dependent phosphorylation of c-Jun   oxide-induced photothermal cancer therapy.  J  Photochem
               N-terminal kinases. Acta Biomater. 2016;46:191-203.  Photobiol B. 2020;208:111913.
               doi: 10.1016/j.actbio.2016.09.018                  doi: 10.1016/j.jphotobiol.2020.111913
            67.  Liu  J,  Dong  J,  Zhang  T, Peng  Q.  Graphene-based   77.  Tabish TA, Pranjol MZ, Jabeen F, et al. Investigation into the
               nanomaterials and their potentials in advanced drug delivery   toxic effects of graphene nanopores on lung cancer cells and
               and cancer therapy. J Control Release. 2018;286:64-73.  biological tissues. Appl Mater Today. 2018;12:389-401.
               doi: 10.1016/j.jconrel.2018.07.034                 doi: 10.1016/j.apmt.2018.07.005
            68.  Orecchioni M, Bedognetti D, Sgarrella F, Marincola FM,   78.  Sontakke AD, Tiwari S, Purkait MK. A  comprehensive
               Bianco  A,  Delogu  LG.  Impact  of  carbon  nanotubes  and   review on  graphene oxide-based nanocarriers: Synthesis,
               graphene on immune cells. J Transl Med. 2014;12:138.  functionalization and biomedical applications.  Flat  Chem.
                                                                  2023;38:100484.
               doi: 10.1186/1479-5876-12-138
                                                                  doi: 10.1016/j.flatc.2023.100484
            69.  Loutfy SA, Salaheldin TA, Ramadan MA, Farroh KY,
               Abdallah ZF, Youssef T. Synthesis, characterization and   79.  Reina G, González-Domínguez JM, Criado A, Vázquez  E,
               cytotoxic evaluation of graphene oxide nanosheets: In vitro   Bianco A, Prato M. Promises, facts and challenges for graphene
               liver cancer model. Asian Pac J Cancer Prev. 2017;18:955-961.  in biomedical applications. Chem Soc Rev. 2017;46:4400-4416.
               doi: 10.22034/APJCP.2017.18.4.955                  doi: 10.1039/C7CS00363C


            Volume 3 Issue 3 (2024)                         11                              doi: 10.36922/gtm.4602
   80   81   82   83   84   85   86   87   88   89   90